GH
Ticker
Guardant Health Inc
Company
Diagnostics
Industry
Healthcare
Sector
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
97.4%81.9%136.5%33.8%30.3%20.3%25.5%31.0% 30.4%
Revenue Growth QoQ
Gross Margin
12.4%36.6%52.3%67.0%67.7%67.1%65.2%59.7%60.8% 63.8%
EBITDA Margin
-159.0%-143.3%-94.7%-33.1%-83.3%-104.0%-113.1%-92.5%-54.3% -44.6%
Operating Margin
-173.7%-153.7%-102.5%-38.4%-88.9%-110.0%-121.1%-100.1%-60.0% -49.0%
Profit Margin
-182.7%-167.0%-93.8%-35.3%-88.5%-108.6%-145.6%-85.0%-59.0% -44.2%
FCF / EBITDA
95.8%110.5%107.7%96.3%66.1%73.1%76.1%66.2%68.5% 65.2%